← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 30, 2020Last known activity
Oct 23, 2025
Timeline
2010s
- Jun 1, 2019
Telios Pharma, Inc.— Founded
Drugs by trial phase (4 distinct, 11 trials)
Phase 2 (4 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT07220408Lead sponsorPhase 2Oct 23, 2025
- NCT06686472Lead sponsorPhase 2Oct 3, 2024
- NCT06293820Lead sponsorPhase 2Apr 11, 2024
- NCT06225973Lead sponsorPhase 2Feb 6, 2024
- NCT06153342Lead sponsorPhase 2Nov 30, 2023
- NCT05745064Lead sponsorPhase 2Feb 27, 2023
- NCT05280509Lead sponsorPhase 1/Phase 2Oct 31, 2022
- NCT04669067Lead sponsorPhase 1/Phase 2Feb 28, 2021
- NCT04640532CollaboratorPhase 1/Phase 2Nov 17, 2020
- NCT04655118Lead sponsorPhase 2Oct 22, 2020
- NCT04419623Lead sponsorPhase 1/Phase 2Jun 30, 2020
Details
- Founded
- San Diego, CA, US Jun 1, 2019
- Last known activity
- Oct 23, 2025